Everything about Forex

Shares of Myriad Genetics Inc. slid in premarket trading Wednesday, a day after the molecular diagnostics company reported a fiscal third-quarter profit and gave a full-year forecast that fell short of Wall Street expectations.
Lesen hier die vollständige Nachricht

Kommentar schreiben

Name (required)

Mail (will not be published) (required)

Website

- UPDATE - HudBay operating results rise; NYSE listing planned (at Reuters)

- [$$] Old Favorites Day (at TheStreet.com)

- RH-Prüfbericht zu Buwog-Deal verschleppt?

- Crush of mud finally plugs BP’s well in the Gulf

- Movers roundup: Denny s, Microsoft (AP)

- Can Back-to-School Shoppers Give July Sales a Boost?